Literature DB >> 19862001

Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study.

C L Meinhold1, Y Park, R Z Stolzenberg-Solomon, A R Hollenbeck, A Schatzkin, A Berrington de Gonzalez.   

Abstract

BACKGROUND: Certain studies suggest that alcohol may reduce the risk of thyroid cancer in women, but the effect in men remains unclear.
METHODS: We analysed the association between alcohol and thyroid cancer in a large (n=490 159) prospective NIH-AARP Diet and Health Study with self-reported beer, wine, and liquor intakes.
RESULTS: Over 7.5 years of follow-up (median), 170 men and 200 women developed thyroid cancer. Overall, the thyroid cancer risk decreased with greater alcohol consumption (> or =2 drinks per day vs none, relative risk=0.57, 95% CI 0.36-0.89, P-trend=0.01).
CONCLUSIONS: These results suggest a potential protective role for alcohol consumption in thyroid cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19862001      PMCID: PMC2778506          DOI: 10.1038/sj.bjc.6605337

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


The rapid increase in thyroid cancer incidence in the United States over the past three decades may be related to changes in certain environmental exposures, as well as increased surveillance and more widespread use of sensitive diagnostic tools (Enewold ). However, despite many retrospective studies, few risk factors have been established other than childhood exposure to ionizing radiation (Dal Maso ). Certain studies have suggested an inverse association between alcohol and thyroid cancer risk, but this may be confounded by cigarette smoking, which is correlated with alcohol consumption and has been inversely related with thyroid cancer (Mack ; Jee ; Nagano ). However, no association was observed in a pooled analysis of 14 case–control studies after adjusting for smoking (Mack ), or in two prospective studies with fewer than 200 cases (Iribarren ; Navarro Silvera ), although these studies were consistent with a small reduction in risk. A larger prospective study in women (421 cases) showed a clear reduction in risk with greater alcohol consumption (Allen ). Although it remains unclear whether an association between alcohol and thyroid cancer exists independently of smoking, there is also a need to investigate effect modification by sex, given the three-fold higher incidence of thyroid cancer in women compared with men (Jemal ). Given the evidence of a possible association and a recent decrease in alcohol consumption in the United States (Zhang ; Kerr ), we analysed the association between alcohol intake and the risk of thyroid cancer and its sub-types in a large US prospective study of over 490 000 participants, including more than 292 000 men.

Materials and methods

The NIH-AARP Diet and Health Study began in 1995–1996 when a questionnaire was mailed to AARP members, aged 50–71 years, residing in six US states (California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania) and two metropolitan areas (Atlanta and Detroit; Schatzkin ). Participant mailings and annual linkage to 11 state cancer registries and the National Death Index provide information on cancer and mortality outcomes. The NIH-AARP Study was approved by the special studies institutional review board of the US National Cancer Institute. Further details on this cohort have been previously described (Schatzkin ). Among 567 169 questionnaire respondents, we excluded individuals who provided duplicate questionnaires (n=179), withdrew from the study (n=6), moved outside the study area or died before follow-up (n=617), were proxy respondents (n=15 760), had prevalent cancer except non-melanoma skin cancer (n=51 193) or end-stage renal disease at baseline (n=997), had cancer identified only from death records (n=3876), or had missing or extreme (greater than twice the interquartile range of sex-specific transformed intake above the 75th or below the 25th percentile) caloric intake (n=4 382). The analytic cohort included 490 159 participants (292 101 men and 198 058 women). We defined incident thyroid cancer cases as first invasive, malignant neoplasm diagnosed during follow-up, and classified histology according to International Classification of Diseases for Oncology, Third Edition codes (C739) (Fritz ). The self-administered baseline questionnaire inquired about health-related behaviours, demographics, and anthropometric characteristics. A supplementary food frequency questionnaire elicited information on regular dietary habits over the past year, including serving sizes and frequency of intake of beer during the summer and rest of the year, wine, and liquor. On the basis of this information, alcohol consumption was standardised according to the MyPyramid Servings database of the US Department of Agriculture. One serving (drink) corresponds to 12 fluid ounces of beer (12.96 g ethanol), 5 fluid ounces of wine (13.72 g ethanol), and 1.5 fluid ounces of 80-proof distilled spirits (13.93 g ethanol). Cox proportional hazards models with attained age as the time metric were used to estimate relative risks (RR) and 95% confidence intervals (CI) for thyroid cancer in all participants and by sex. Models were additionally adjusted for sex, race, smoking status, body mass index (BMI), and family history of cancer. We mutually adjusted for beer, wine, and liquor in models of alcohol type. Medians of each exposure category were modeled as continuous in trend tests. Sub-group analyses were conducted using categories of sex, smoking status, BMI, and thyroid cancer histology. The heterogeneity within sub-groups was assessed using the Q statistic (Cochran, 1954). We found no evidence that the proportional hazards assumption was violated.

Results

The median alcohol intake among participants reporting any alcohol consumption over the past year was 4.5 g per day, or approximately one-third of the amount of a standard alcoholic drink. Over 11% of the cohort (9574 women and 45 149 men) reported consuming two or more alcoholic drinks daily. There were higher proportions of beer or liquor drinkers among the heavier drinking groups, and of wine drinkers among the more moderate drinking group. Compared with non-drinkers, heavier drinkers were more likely to be male, white non-Hispanic, more educated, and to have ever smoked, and less likely to be obese (Table 1).
Table 1

Study characteristics by alcohol intake (medians or percentage), using the NIH-AARP Diet and Health Study (n=490 159)

  Alcohol (drinks)
  None <1 per week 1–6 per week 1–2 per day ⩾2 per day
Study participants119 172131 726127 34057 19854 723
Alcohol (drinks per day)00.060.381.343.66
Alcohol (g per day)00.795.1617.9150.84
      
Drinking pattern (%)
 Mostly beer drinkersN/A20272333
 Mostly wine drinkersN/A42363618
 Mostly liquor drinkersN/A28243646
 MixedN/A101354
 Age at entry63.062.462.163.162.6
      
Sex (%)      
 Women4954342818
 Men5146677283
      
Race/ethnicity (%)
 White, non-Hispanic8791939595
 Black, non-Hispanic64322
 Other44332
 Missing21111
      
Education (%)
 Less than high school3528201820
 High school graduate1011999
 Some college2224242324
 College graduate2935444945
 Missing43322
      
Body mass index (%)
 <25 kg m−23234364034
 25–29.9 kg m−23939444446
 ⩾30 kg m−22624181518
 Missing32222
      
Cigarette smoking status (%)
 Never4341332618
 Former4244535860
 Current1112101219
 Missing44444
      
Family history of cancer (%)
 No4646464647
 Yes4849494948
 Missing65555

Gram intake of specific alcohol type accounts for 750% of total alcohol intake.

Over a median 7.5 years of follow-up, 200 women and 170 men were diagnosed with thyroid cancer. Compared with non-drinking, consuming two or more drinks per day was associated with a significantly decreased risk (RR=0.57, 95% CI 0.36–0.89, P-trend=0.01; Table 2). Consuming one or more drinks per day of beer was associated with a decreased risk when compared with no beer drinking, particularly in men (RR=0.47, 95% CI 0.22–0.97, P-trend=0.03). No clear dose-response associations with wine were observed, but liquor intake was associated with a nonsignificant decreased risk in women.
Table 2

Association between the level of alcohol intake and thyroid cancer risk, using the NIH-AARP Diet and Health Study, (n=490 159)

  Total (n=490 159)
Women (n=198 058)
Men (n=292 101)
  Cases/person- years RRa RR (95% CI)b Cases/person- years RRa RR (95% CI)b Cases/person- years RRa RR (95% CI)b
Alcohol (drinks)
 None109/812 3761.001.00 (Reference)71/405 6681.001.00 (Reference)38/406 7081.001.00 (Reference)
 <1 per week109/913 6270.880.87 (0.66–1.13)70/503 8760.800.81 (0.58–1.14)39/409 7511.020.97 (0.62–1.51)
 1–6 per week96/878 4880.890.87 (0.66–1.16)43/300 0160.830.84 (0.57–1.24)53/578 4730.990.90 (0.59–1.38)
 1–2 per day32/393 0920.670.67 (0.44–1.00)16/176 9830.52c0.55 (0.31–0.95)c20/282 0640.760.69 (0.40–1.20)
 ⩾2 per day24/369 8860.570.57 (0.36–0.89)20/303 9310.710.64 (0.37–1.12)
P-trend  0.01  0.06  0.08
          
Beer (drinks) d , e
 None195/1 542 4261.001.00 (Reference)135/896 0731.001.00 (Reference)60/646 3531.001.00 (Reference)
 <1 per week128/1 111 2201.021.02 (0.79–1.32)56/398 7731.011.02 (0.72–1.44)72/712 4470.990.99 (0.66–1.48)
 1–6 per week38/481 5300.790.79 (0.53–1.17)9/91 6970.72f0.75 (0.37–1.49)f29/408 5430.710.72 (0.44–1.21)
 ⩾1 per day9/232 2930.400.42 (0.21–0.83)9/213 5830.430.47 (0.22–0.97)
P-trend  0.01  0.40  0.03
          
Wine (drinks) e , g
 None147/1 317 6991.001.00 (Reference)82/549 4271.001.00 (Reference)65/768 2721.001.00 (Reference)
 <1 per week145/1 267 5101.071.05 (0.81–1.37)80/556 2311.091.10 (0.77–1.55)65/711 2791.050.99 (0.67–1.48)
 1–6 per week61/556 3991.111.09 (0.77–1.54)30/204 0151.161.15 (0.71–1.86)31/352 3841.081.00 (0.61–1.63)
 ⩾1 per day17/225 8630.770.76 (0.45–1.29)8/76 8700.810.83 (0.39–1.77)9/148 9930.730.69 (0.33–1.43)
P-trend  0.69  0.62  0.33
          
Liquor (drinks) e , h
 None187/1 575 6031.001.00 (Reference)117/725 5121.001.00 (Reference)70/850 0911.001.00 (Reference)
 <1 per week124/1 145 8790.930.93 (0.71–1.20)63/493 0540.780.79 (0.56–1.11)61/652 8251.201.15 (0.77–1.72)
 1–6 per week27/332 3260.790.79 (0.51–1.22)12/92 1270.790.82 (0.44–1.54)15/240 1990.870.81(0.44–1.50)
 ⩾1 per day32/313 6601.021.02 (0.68–1.53)8/75 8490.650.70 (0.33–1.47)24/237 8111.401.25 (0.74–2.11)
P-trend  0.80  0.46  0.52

Adjusted for age and sex.

Adjusted for age, sex, race (non-Hispanic white, non-Hispanic black, other, or missing), education (less than high school, high school graduate, some college, college graduate, or missing), smoking status (never, former, current, or missing), body mass index (BMI <25, 25–29.9, ⩾30 kgm−2, or missing), and family history of cancer (no, yes, or missing).

Relative risks for ⩾1 drink per day vs none.

One standardized drink of beer is equal to 12.96 g of alcohol.

Beer, wine, and liquor were mutually adjusted for in age- and sex-adjusted and multivariable-adjusted models.

Relative risks for ⩾1 drinks per week vs none.

One standardized drink of wine is equal to 13.72 g of alcohol.

One standardized drink of liquor is equal to 13.93 g of alcohol.

The strength of the inverse association with alcohol intake was relatively consistent according to sex, smoking status, and BMI categories, as well as histology (Figure 1). It was stronger in participants who never smoked (RR=0.33, 95% CI 0.16–0.71) when compared with ever smokers (RR=0.78, 95% CI 0.51–1.19; P-heterogeneity=0.05). Although we observed a clearer inverse association for papillary (RR=0.58, 95% CI 0.38–0.88) as compared with follicular cancer (RR=0.86, 95% CI 0.41–1.80), these results were not significantly different (P-heterogeneity=0.36). For every 10 g consumed, the RRs for thyroid cancer were 0.95 (95% CI 0.89–1.01) for men, 0.84 (95% CI 0.71–1.01) for women, and 0.94 (95% CI 0.88–0.99) for men and women combined. The results were not materially altered after excluding the first 2 years of follow-up, when the lightest drinkers were considered as the referent category, or when models were additionally adjusted for smoking intensity (data not shown).
Figure 1

Associations between alcohol intake (⩾1 drink per day vs none) and thyroid cancer risk by sex, smoking status, body mass index (BMI), and histological type, using the NIH-AARP Diet and Health Study (n=490 159). The models were adjusted for age, sex, race (non-Hispanic white, non-Hispanic black, other, or missing), education (less than high school, high school graduate, some college, college graduate, or missing), smoking status (never, former, current, or missing), body mass index (BMI<25.25−29.9, ⩾30 kg m−2 or missing), and family history of cancer (no, yes, or missing).

Discussion

In this large prospective study, we observed that greater alcohol intake was associated with a reduced risk of thyroid cancer in both men and women, independent of cigarette smoking. The inverse association for beer seemed stronger than for wine or liquor, particularly among men in this cohort. In women, we observed a nonsignificant inverse association for liquor intake, but no clear association for other alcohol types. These differences may reflect the smaller range of alcohol intake in women, residual confounding by socioeconomic status or related factors, drinking patterns (i.e., binge drinking), or differences in measurement error by the type of alcohol. Nonetheless, similar dose-response associations with total alcohol intake were observed by sex, and associations by alcohol type were generally in the same inverse direction. Although we observed a clearer reduction in risk for papillary vs follicular cancers, this difference was not significant. However, there were only 64 follicular cancers in this study. Given the strong, positive correlation between alcohol and smoking, and the evidence linking smoking with a reduced risk of thyroid cancer (Mack ; Jee ; Nagano ), residual confounding by smoking may have biased our results away from the null. However, this seems unlikely as a stronger inverse association for alcohol was observed for never when compared with ever cigarette smokers. In a cross-sectional study using ultrasonography, an inverse association between alcohol consumption and thyroid enlargement and nodularity was observed (Knudsen ). A positive association between alcohol consumption and thyroid-stimulating hormone (TSH) and an inverse association with serum T3 was also found. Thyroid-stimulating hormone, which is secreted by the pituitary in response to low thyroid hormone levels in the blood, is known to increase the proliferation of follicular thyroid cells in laboratory studies (Williams, 1990), although its effect in humans is not clearly established. Alcohol may protect the thyroid from elevated TSH by inhibiting thyroid hormone metabolism (Knudsen ). Greater alcohol intake may lead to vitamin deficiencies, impaired folate metabolism, oxidative stress, and DNA damage (Boffetta and Hashibe, 2006); but whether these directly influence the thyroid is unknown. This is one of the few prospective studies to examine the relation between alcohol and thyroid cancer risk. A reasonably large number of cases allowed for sub-group analyses by sex, BMI, smoking status, and thyroid cancer sub-types; however, there were too few cases to obtain stable RRs in the heavier-drinking categories (⩾2 drinks per day). Participants reported intake during the past year, which obviously does not cover cumulative lifetime drinking, and our results could be attenuated by the inclusion of recent quitters in the reference category of non-drinkers. However, excluding the first 2 years of follow-up did not materially change the results, and a similar inverse dose-response association was observed when the lightest drinkers were the referent group. In this large prospective study, we found a reduction in thyroid cancer risk in both men and women with a greater consumption of alcohol. The decrease in risk associated with consuming 10 g per day is reasonably consistent between women in this study and in another large prospective study (16 vs 25% per 10 g per day; Allen ). However, the direct public health applications of these findings are limited, considering the evidence linking moderate-to-heavy alcohol consumption with increases in several cancers, among other adverse effects (Boffetta and Hashibe, 2006). Nonetheless, as thyroid cancer incidence is rising, it is important to analyse the influence of diet and lifestyle in its aetiology.
  15 in total

1.  A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea.

Authors:  Wendy J Mack; Susan Preston-Martin; Luigino Dal Maso; Rosaria Galanti; Min Xiang; Silvia Franceschi; Arne Hallquist; Fan Jin; Laurence Kolonel; Carlo La Vecchia; Fabio Levi; Athena Linos; Eiliv Lund; Anne McTiernan; Kiyohiko Mabuchi; Eva Negri; Gun Wingren; Elaine Ron
Journal:  Cancer Causes Control       Date:  2003-10       Impact factor: 2.506

Review 2.  TSH and thyroid cancer.

Authors:  E D Williams
Journal:  Horm Metab Res Suppl       Date:  1990

3.  Risk factors for thyroid cancer: a prospective cohort study.

Authors:  Stephanie A Navarro Silvera; Anthony B Miller; Thomas E Rohan
Journal:  Int J Cancer       Date:  2005-09-01       Impact factor: 7.396

4.  Cohort study of thyroid cancer in a San Francisco Bay area population.

Authors:  C Iribarren; T Haselkorn; I S Tekawa; G D Friedman
Journal:  Int J Cancer       Date:  2001-09-01       Impact factor: 7.396

5.  Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

Authors:  A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

6.  Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules.

Authors:  N Knudsen; I Bülow; P Laurberg; H Perrild; L Ovesen; T Jørgensen
Journal:  Clin Endocrinol (Oxf)       Date:  2001-07       Impact factor: 3.478

Review 7.  Alcohol and cancer.

Authors:  Paolo Boffetta; Mia Hashibe
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

8.  Secular trends in alcohol consumption over 50 years: the Framingham Study.

Authors:  Yuqing Zhang; Xinxin Guo; Richard Saitz; Daniel Levy; Emily Sartini; Jingbo Niu; R Curtis Ellison
Journal:  Am J Med       Date:  2008-08       Impact factor: 4.965

9.  Smoking and cancer risk in Korean men and women.

Authors:  Sun Ha Jee; Jonathan M Samet; Heechoul Ohrr; Jung Hee Kim; Il Soon Kim
Journal:  Cancer Causes Control       Date:  2004-05       Impact factor: 2.506

10.  A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer.

Authors:  Jun Nagano; Kiyohiko Mabuchi; Yasuhiko Yoshimoto; Yuzo Hayashi; Nobuo Tsuda; Charles Land; Kazunori Kodama
Journal:  J Epidemiol       Date:  2007-05       Impact factor: 3.211

View more
  18 in total

1.  Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.

Authors:  Briseis Aschebrook-Kilfoy; Gila Neta; Alina V Brenner; Amy Hutchinson; Ruth M Pfeiffer; Erich M Sturgis; Li Xu; William Wheeler; Michele M Doody; Stephen J Chanock; Alice J Sigurdson
Journal:  Endocr Relat Cancer       Date:  2012-05-24       Impact factor: 5.678

2.  Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies.

Authors:  Cari M Kitahara; Elizabeth A Platz; Laura E Beane Freeman; Ann W Hsing; Martha S Linet; Yikyung Park; Catherine Schairer; Arthur Schatzkin; James M Shikany; Amy Berrington de González
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-25       Impact factor: 4.254

3.  Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study.

Authors:  S J Schonfeld; E Ron; C M Kitahara; A Brenner; Y Park; A J Sigurdson; A Schatzkin; A Berrington de González
Journal:  Cancer Epidemiol       Date:  2011-08-17       Impact factor: 2.984

4.  Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States.

Authors:  Cari M Kitahara; Martha S Linet; Laura E Beane Freeman; David P Check; Timothy R Church; Yikyung Park; Mark P Purdue; Catherine Schairer; Amy Berrington de González
Journal:  Cancer Causes Control       Date:  2012-07-29       Impact factor: 2.506

5.  Thyroidology and public health: The challenges ahead.

Authors:  Sanjay Kalra; Ambika Gopalakrishnan Unnikrishnan; Rakesh Sahay
Journal:  Indian J Endocrinol Metab       Date:  2011-07

Review 6.  Dietary factors and the risk of thyroid cancer: a review.

Authors:  Wook Jin Choi; Jeongseon Kim
Journal:  Clin Nutr Res       Date:  2014-07-29

7.  Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors.

Authors:  Jun Park; Hyunju Park; Tae Hyuk Kim; Sun Wook Kim; Hye Won Jang; Jae Hoon Chung
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

8.  Changes in Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study.

Authors:  Yohwan Yeo; Kyungdo Han; Dong-Wook Shin; Dahye Kim; Su-Min Jeong; Sohyun Chun; In-Young Choi; Keun-Hye Jeon; Tae-Hyuk Kim
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

9.  Impact of alcohol use on thyroid function.

Authors:  Yatan Pal Singh Balhara; Koushik Sinha Deb
Journal:  Indian J Endocrinol Metab       Date:  2013-07

10.  Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study.

Authors:  Abhijit Sen; Konstantinos K Tsilidis; Naomi E Allen; Sabina Rinaldi; Paul N Appleby; Martin Almquist; Julie A Schmidt; Christina C Dahm; Kim Overvad; Anne Tjønneland; Agnetha L Rostgaard-Hansen; Françoise Clavel-Chapelon; Laura Baglietto; Marie-Christine Boutron-Ruault; Tilman Kühn; Verena A Katze; Heiner Boeing; Antonia Trichopoulou; Christos Tsironis; Pagona Lagiou; Domenico Palli; Valeria Pala; Salvatore Panico; Rosario Tumino; Paolo Vineis; Hb As Bueno-de-Mesquita; Petra H Peeters; Anette Hjartåker; Eiliv Lund; Elisabete Weiderpass; J Ramón Quirós; Antonio Agudo; María-José Sánchez; Larraitz Arriola; Diana Gavrila; Aurelio Barricarte Gurrea; Ada Tosovic; Joakim Hennings; Maria Sandström; Isabelle Romieu; Pietro Ferrari; Raul Zamora-Ros; Kay-Tee Khaw; Nicholas J Wareham; Elio Riboli; Marc Gunter; Silvia Franceschi
Journal:  Br J Cancer       Date:  2015-08-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.